Strippoli GF - Search Results

1

Research Priorities in CKD: Report of a National Workshop Conducted in Australia.

Tong A, Crowe S, Chando S, Cass A, Chadban SJ, Chapman JR, Gallagher M, Hawley CM, Hill S, Howard K, Johnson DW, Kerr PG, McKenzie A, Parker D, Perkovic V, Polkinghorne KR, Pollock C, Strippoli GF, Tugwell P, Walker RG, Webster AC, Wong G, Craig JC. Tong A, et al. Among authors: strippoli gf. Am J Kidney Dis. 2015 Aug;66(2):212-22. doi: 10.1053/j.ajkd.2015.02.341. Epub 2015 May 2. Am J Kidney Dis. 2015. PMID: 25943716

2

Haemoglobin and haematocrit targets for the anaemia of chronic renal disease.

Strippoli GF, Manno C, Schena FP, Craig JC. Strippoli GF, et al. Cochrane Database Syst Rev. 2003;(1):CD003967. doi: 10.1002/14651858.CD003967. Cochrane Database Syst Rev. 2003. PMID: 12535495 Updated. Review.

3

The number, quality, and coverage of randomized controlled trials in nephrology.

Strippoli GF, Craig JC, Schena FP. Strippoli GF, et al. J Am Soc Nephrol. 2004 Feb;15(2):411-9. doi: 10.1097/01.asn.0000100125.21491.46. J Am Soc Nephrol. 2004. PMID: 14747388 Review.

4

Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.

Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC. Flanc RS, et al. Among authors: strippoli gf. Am J Kidney Dis. 2004 Feb;43(2):197-208. doi: 10.1053/j.ajkd.2003.10.012. Am J Kidney Dis. 2004. PMID: 14750085 Review.

5

Treatment for lupus nephritis.

Flanc RS, Roberts MA, Strippoli GF, Chadban SJ, Kerr PG, Atkins RC. Flanc RS, et al. Among authors: strippoli gf. Cochrane Database Syst Rev. 2004;(1):CD002922. doi: 10.1002/14651858.CD002922.pub2. Cochrane Database Syst Rev. 2004. PMID: 14973998 Updated. Review.

6

Antimicrobial agents to prevent peritonitis in peritoneal dialysis: a systematic review of randomized controlled trials.

Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Strippoli GF, et al. Am J Kidney Dis. 2004 Oct;44(4):591-603. Am J Kidney Dis. 2004. PMID: 15384009 Review.

7

Effects of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists on mortality and renal outcomes in diabetic nephropathy: systematic review.

Strippoli GF, Craig M, Deeks JJ, Schena FP, Craig JC. Strippoli GF, et al. BMJ. 2004 Oct 9;329(7470):828. doi: 10.1136/bmj.38237.585000.7C. Epub 2004 Sep 30. BMJ. 2004. PMID: 15459003 Free PMC article. Review.

8

Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Strippoli GF, et al. J Am Soc Nephrol. 2004 Oct;15(10):2735-46. doi: 10.1097/01.ASN.0000141463.95561.79. J Am Soc Nephrol. 2004. PMID: 15466279 Review.

9

Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.

Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Strippoli GF, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004679. doi: 10.1002/14651858.CD004679.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495124 Updated. Review.

10

Catheter type, placement and insertion techniques for preventing peritonitis in peritoneal dialysis patients.

Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Strippoli GF, et al. Cochrane Database Syst Rev. 2004 Oct 18;(4):CD004680. doi: 10.1002/14651858.CD004680.pub2. Cochrane Database Syst Rev. 2004. PMID: 15495125 Updated. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

306 results

Search Page